Sanofi Korea Corporation (hereinafter referred to as Sanofi) successfully concluded the RSV story contest\ for parents who ...

Poster presentations of both ADC candidates “drew significant attention from the attendees” at the oncology meeting, Incheon, ...

SEOUL, South Korea (AP) — North Korea boasted Friday that the new intercontinental ballistic missile it just test-launched is “the world’s strongest,” a claim seen as pure propaganda after ...

Some 8,000 North Korean soldiers are now in Russia near Ukraine’s border and are preparing to help the Kremlin fight against Ukrainian troops in the coming days, the Biden administration said ...

The launch, into waters west of Japan, came shortly after the United States and South Korea criticized the North for sending troops to join Russia’s war. By Choe Sang-Hun Reporting from Seoul ...

North Korea said it tested a new intercontinental ballistic missile on Thursday morning, a launch believed to have achieved the longest flight time yet for a North Korean missile. The new ...

North Korean troops are likely to join combat operations against Ukrainian forces inside Russia in the “coming days” after about 8,000 of them have been deployed to the occupied Kursk region ...

North Korea is “very likely to ask” Moscow for advanced technology related to nuclear weapons in exchange for deploying troops to help Russia in its war against Ukraine, South Korean Defense ...

Latest analysis reveals key trends and opportunities in the Multiple System Atrophy (MSA) market, highlighting advancements in treatment options. BURLINGAME, CA, UNITED STATES, October 30, 2024 ...

SEOUL — North Korean troops deployed to Russia have begun to make their way toward the border with Ukraine, Defense Secretary Lloyd Austin said Wednesday, adding that it would be “very ...

The Pentagon said there are now 10,000 North Korean troops in Russia. LONDON -- North Korea's Foreign Minister Choe Son-hui left Pyongyang on Monday night for an official visit to Russia ...

(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...